Legend Biotech(LEGN) - 2022 Q1 - Quarterly Report

Exhibit 99.1 Legend Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights SOMERSET, N.J.--(BUSINESS WIRE)--March 18, 2022--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies, today reported unaudited financial results for the fourth quarter of 2021. "Legend Biotech ended the fourth quarter with strong data on our lead product candidate and nearly $900 million in cash," sa ...